Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: A systematic review and meta-analysis
- 1 June 2020
- journal article
- review article
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 51, 101983
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Effects of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation on Serum Brain-Derived Neurotrophic Factor Levels in Patients with DepressionFrontiers in Psychiatry, 2012
- The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 miceActa Pharmacologica Sinica, 2010
- Correlations and Discrepancies between Serum and Brain Tissue Levels of Neurotrophins after Electroconvulsive Treatment in RatsPharmacopsychiatry, 2009
- Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patientsNeuroscience Letters, 2009
- Neurotrophic factors in serum following ECT: A pilot studyThe World Journal of Biological Psychiatry, 2009
- Increased Plasma Concentration of Brain-Derived Neurotrophic Factor With Electroconvulsive TherapyThe Journal of Clinical Psychiatry, 2007
- Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patientsEuropean Neuropsychopharmacology, 2006
- Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- How does an axon grow?Genes & Development, 2003
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionCell, 2003